Scarica l'app Stockscreener
8.52
4.09%
0.335
Dopo l'orario di chiusura:
8.52
Precedente Chiudi:
$8.185
Aprire:
$8.22
Volume 24 ore:
142.96K
Relative Volume:
1.47
Capitalizzazione di mercato:
$147.04M
Reddito:
-
Utile/perdita netta:
$-33.82M
Rapporto P/E:
-0.333
EPS:
-25.5891
Flusso di cassa netto:
$-66.04M
1 W Prestazione:
+1.01%
1M Prestazione:
-4.38%
6M Prestazione:
+12.11%
1 anno Prestazione:
+68.05%
Intervallo 1D:
$8.22
$8.78
Intervallo di 1 settimana:
$7.9001
$8.78
Portata 52W:
$4.60
$12.62
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Nome
Elicio Therapeutics Inc
Settore
Industria
Telefono
(857) 209-0050
Indirizzo
451 D STREET, 5TH FLOOR, BOSTON
Confronta ELTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
8.52 | 141.26M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Elicio Therapeutics Inc Borsa (ELTX) Ultime notizie
Understanding Momentum Shifts in (ELTX) - news.stocktradersdaily.com
Elicio Therapeutics (ELTX) upgraded to buy: Here's why - MSN
Elicio’s cancer vaccine triggers broad anti-tumor immunity - Rare Cancer News
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why - sharewise.com
Elicio reports antigen spreading in 87% of evaluated cancer patients By Investing.com - Investing.com Australia
Elicio reports antigen spreading in 87% of evaluated cancer patients - Investing.com India
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial - Yahoo Finance
Pancreatic Ductal Adenocarcinoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Elicio Therapeutics, Cend Therapeutics, Silenseed, Amplia - Barchart.com
How Elicio Therapeutics Inc. (9HA) stock reacts to stronger dollarQuarterly Market Summary & Safe Capital Allocation Plans - Newser
How Elicio Therapeutics Inc. (9HA) stock reacts to new regulations2025 Winners & Losers & Long-Term Growth Plans - Newser
Will Elicio Therapeutics Inc. (9HA) stock benefit from mergersTrade Ideas & Risk Controlled Swing Trade Alerts - Newser
Avoiding Lag: Real-Time Signals in (ELTX) Movement - news.stocktradersdaily.com
Can Elicio Therapeutics Inc. stock deliver surprise earnings beat2025 Volatility Report & Real-Time Buy Zone Alerts - Newser
Can Elicio Therapeutics Inc. (9HA) stock sustain margin levelsAnalyst Downgrade & Safe Capital Growth Plans - Newser
Will Elicio Therapeutics Inc. stock benefit from AI adoptionWeekly Stock Recap & Weekly Stock Performance Updates - Newser
How Elicio Therapeutics Inc. (9HA) stock trades in high volatilityWeekly Trade Recap & Weekly Return Optimization Alerts - Newser
Is Elicio Therapeutics Inc. (9HA) stock undervalued historicallyTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Will Elicio Therapeutics Inc. (9HA) stock split increase liquidity2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
How Elicio Therapeutics Inc. (9HA) stock compares with top peers - Newser
Why Elicio Therapeutics Inc (ELTX) Is Skyrocketing So Far In 2025 - MSN
Discipline and Rules-Based Execution in ELTX Response - news.stocktradersdaily.com
Can Elicio Therapeutics Inc. (9HA) stock sustain breakout momentumQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Is Elicio Therapeutics Inc. stock a smart buy before Fed meeting2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Why Elicio Therapeutics Inc. (9HA) stock remains stableProfit Target & Consistent Return Investment Signals - newser.com
How Elicio Therapeutics Inc. stock performs in weak economyJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Can Elicio Therapeutics Inc. stock maintain operating marginsQuarterly Growth Report & Stock Timing and Entry Methods - newser.com
Retail investors are Elicio Therapeutics, Inc.'s (NASDAQ:ELTX) biggest owners and were hit after market cap dropped US$8.5m - simplywall.st
How Elicio Therapeutics Inc. (9HA) stock performs during market turbulenceJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - newser.com
Can Elicio Therapeutics Inc. stock outperform in 2025 bull market2025 Biggest Moves & Free High Accuracy Swing Entry Alerts - newser.com
How high can Elicio Therapeutics Inc. stock goJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com
Elicio Therapeutics appoints Marc Wolfgang as chief technology officer By Investing.com - Investing.com Nigeria
Elicio Therapeutics Inc. stock trendline breakdownTrade Entry Summary & Low Volatility Stock Suggestions - newser.com
What earnings revisions data tells us about Elicio Therapeutics Inc.Trade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
Elicio Therapeutics, Inc. Appoints Marc J. Wolfgang, M.S. as Chief Technology Officer - MarketScreener
Elicio Therapeutics appoints Marc Wolfgang as chief technology officer - Investing.com
Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer - The Manila Times
Elicio Therapeutics Appoints Veteran CMC and Technical - GlobeNewswire
Will Elicio Therapeutics Inc. outperform the marketPortfolio Risk Summary & Accurate Buy Signal Alerts - newser.com
Elicio Therapeutics Inc Azioni (ELTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):